Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-20
1992-02-04
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514374, 514385, 514386, 514392, A61K 3142, A61K 31415
Patent
active
050860666
ABSTRACT:
The present invention relates to the application of substituted benzamides of formula (I): ##STR1## in which: A is diethylaminoethyl, 1-ethyl-2-pyrrolidinylmethyl or 1-allyl-2-pyrrolidinylmethyl;
REFERENCES:
patent: 4210660 (1980-07-01), Takashima et al.
patent: 4835172 (1989-05-01), Acher et al.
patent: 4877780 (1989-10-01), Vega-Noverola et al.
patent: 4914117 (1990-04-01), Acher et al.
Chemical Abstracts (108:37828a) 1988.
Chemical Abstracts (111:146821a).
Harrington et al., "Metaclopramide--An Updated Review of its Pharmacological Properties and Clinical Use", Drug, vol. 25, pp. 463-464 (1983).
Crawley et al., Pharmacology, Biochemistry and Behavior, vol. 15, pp. 695-699 (1981).
Costall et al., Neuropharmacology, vol. 26, pp. 195-200 (1987).
Acher Jacques
Costall Brenda
Gardaix-Luthereau Renee
Monier Jean-Claude
Naylor Robert
Laboratoires Delagrange Societe d'Applications Pharmacodnymiques
Waddell Frederick E.
Weddington K.
LandOfFree
Method of providing anxiolytic and antipsychotic treatment with does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of providing anxiolytic and antipsychotic treatment with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of providing anxiolytic and antipsychotic treatment with will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-348210